Search results

Jump to navigation Jump to search
  • **Laboratory for Vaccine-Preventable Diseases
    3 KB (461 words) - 08:31, 11 September 2023
  • ...ww.cdc.gov/ncidod/dbmd/diseaseinfo/typhoidfever_t.htm}}</ref> There is a [[vaccine]], but recommended only for travelers to endemic areas.<ref name=MMWR>{{cit
    3 KB (424 words) - 14:34, 2 February 2023
  • ...most recent application of ''Lactococcus lactis'' is in the development of vaccine delivery systems. ''L. lactis'' can be genetically engineered to generate ...is outcome has encouraged the further development of a L. lactis based HIV vaccine.<ref>[http://www.ncbi.nlm.nih.gov/pubmed/12649143 Xin KQ., Hoshino, Y., Tod
    11 KB (1,702 words) - 20:47, 8 November 2013
  • ...lly in the fact that we can use something harmful, and turn into a cure or vaccine that may help someone in need.
    3 KB (404 words) - 03:40, 22 November 2023
  • ...TP-Polio-Hib (diphtheria/tetanus/pertussis/polio/haemophilus influenzae b) vaccine, are given at the ages of two, three, and four months, followed by a [[Boos
    3 KB (473 words) - 02:15, 15 November 2007
  • {{r|Vaccine}}
    4 KB (486 words) - 19:46, 11 January 2010
  • ...rom affecting a treated animal, yet distemper is still prevalent since the vaccine is not accessible to all animals that are susceptible to the virus.<ref>[ht
    8 KB (1,179 words) - 16:32, 7 November 2013
  • ...wever, this vaccine is not commercially available in the United States. A vaccine for use in animals has also been developed, but it is not available in the
    9 KB (1,339 words) - 12:54, 4 April 2009
  • ...oyola.edu/~klc/BL472/Malaria/research.html Erin McNamara, Current drug and vaccine research on malaria]</ref>
    12 KB (1,931 words) - 23:28, 26 October 2013
  • ...ces a Protective Immune Response in Mice with Lyme Disease. ''Clinical and Vaccine Immunology, 15''. (9), 1429-1435</ref>
    10 KB (1,451 words) - 04:06, 16 February 2010
  • ...and human papillomavirus (HPV), and the recent recommendations for the HPV vaccine."
    3 KB (340 words) - 12:57, 3 November 2007
  • Vaccines are not widely available for STDs. An [[HPV vaccine]] has recently been released for protection against certain, but not all, s
    3 KB (499 words) - 04:31, 22 November 2023
  • ...accine.2008.02.015 "Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protecti ...C. sinensis. ''B. subtilis'' spores, thus, are a promising potential oral vaccine vehicle for the prevention and control of clonorchiasis and other gastroint
    16 KB (2,248 words) - 05:12, 30 October 2013
  • ...cal warfare research center. Not all personnel there were protected by the vaccine, and it is not recommended for post-exposure prophylaxis, but only for labo
    10 KB (1,405 words) - 04:47, 26 October 2013
  • ...vive for long periods of time. These genes are important when developing a vaccine for CMV. Currently, there is no vaccine for CMV, but preventative measures can be taken to keep from getting the vi
    21 KB (3,267 words) - 20:07, 1 November 2013
  • ...f Meta-Analysis: Nicotine Gum and Smoking Cessation and the Effcacy of BCG Vaccine in the Treatment of Tuberculosis]" in "A Handbook of Statistical Analyses U
    5 KB (671 words) - 11:50, 1 July 2012
  • A large outbreak was secondary to the 1976 swine influenza vaccine.
    4 KB (489 words) - 16:48, 19 August 2010
  • ...ine from a licenced veterinarian, followed by 2 more shots of the modified vaccine until the puppy is around the age of 16 weeks. It is recommended that dogs
    7 KB (1,155 words) - 00:59, 12 February 2010
  • ...the [[United Kingdom]] regarding a potential link between the combined MMR vaccine (vaccinating children from mumps, measles and rubella) and autism prompted
    8 KB (1,223 words) - 13:22, 2 February 2023
  • ...risk-benefit there in populations where, variously, the non-universal HPV vaccine is used widely, and, for that matter, in populations that have regular cerv
    4 KB (574 words) - 09:25, 21 November 2010
View ( | ) (20 | 50 | 100 | 250 | 500)